Project Affinity: Excess Cancer Blood Testing
1 other identifier
observational
613
1 country
1
Brief Summary
Study investigating cancer blood samples on an iterative measurement systme
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2021
CompletedFirst Posted
Study publicly available on registry
January 26, 2021
CompletedStudy Start
First participant enrolled
April 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedSeptember 29, 2022
September 1, 2022
1.4 years
January 22, 2021
September 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Viability of measurement technique
Viability of measurement technique
12 months
Interventions
No drug used
Eligibility Criteria
Above 18 years of age. Undergoing SACT treatment. Going to hospital for routine blood tests.
You may qualify if:
- Undergoing SACT
- Routine blood tests
You may not qualify if:
- Not had first cycle of SACT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Entia Ltdlead
Study Sites (1)
The Christie NHS Foundation Trust
Manchester, United Kingdom
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2021
First Posted
January 26, 2021
Study Start
April 15, 2021
Primary Completion
August 31, 2022
Study Completion
August 31, 2022
Last Updated
September 29, 2022
Record last verified: 2022-09